Alessandra Bosch/LinkedIn
Jul 22, 2026, 09:29
Alessandra Bosch: Presenting the Latest Evidence in Pediatric Anticoagulation at ISTH 2026
Alessandra Bosch, Attending Physician at Zurich Children’s Hospital, Clinician Scientist at University of Zurich, shared on LinkedIn:
”What a HOT week at ISTH 2026 in Paris!
Grateful for the chance and honour to give a state-of-the-art talk on periprocedural anticoagulation management in children, and to present our poster on real-world rivaroxaban use in children to such an engaged community.
But beyond the science, ISTH is always about the people!
Reconnecting with long-time colleagues, and making new connections that will turn into future collaborations.
Thank you to everyone who stopped by to chat, ask questions, or just say hello.
On to the next one.”
Stay updated with Hemostasis Today.
-
Sep 13, 2026, 17:08W. Alberto Sifuentes Giraldo: Urticarial Vasculitis Clinical Features, Systemic Involvement, and Treatment
-
Sep 13, 2026, 16:58Let’s Debunk Some Myths about Blood in SCD – ASCO
-
Sep 13, 2026, 16:56William Wallace: A Magnesium Ion Decides Whether Your Brain Learns or Not
-
Sep 13, 2026, 16:54Meet NBDF’s 2026 Excellence Fellowship Recipients – National Bleeding Disorders Foundation
-
Sep 13, 2026, 16:52Kaloyan Takov: Native Lp(a) Carries a Distinct Triglyceride Signature Linked to Cardiovascular Disease
-
Sep 13, 2026, 16:51Axay Tomar: How Simulation-Based Education Shapes Safer Transfusion Practices
-
Sep 13, 2026, 16:51Edina Cenko: AZURE-HeFH Highlights the LDL-C Treatment Gap in HeFH
-
Sep 13, 2026, 16:49William Aird: Why Is LDH Elevated In Splenic Infarction?
-
Sep 13, 2026, 16:48David McIntosh: PPTA Calls for Action on the Global Shortage of Plasma-Derived Medicines